Trials / Conditions / Advanced Pancreatic Carcinoma

Advanced Pancreatic Carcinoma

13 registered clinical trials studyying Advanced Pancreatic Carcinoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced NCT06906562	Sameek Roychowdhury	Phase 2
Active Not Recruiting	A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Brea NCT06630325	OHSU Knight Cancer Institute	Phase 2
Recruiting	At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860	Mayo Clinic	Phase 2
Recruiting	CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Pati NCT05733000	Northwestern University	Phase 2
Withdrawn	SMMART Adaptive Clinical Treatment (ACT) Trial NCT05238831	OHSU Knight Cancer Institute	EARLY_Phase 1
Recruiting	First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patien NCT05759923	Molecure S.A.	Phase 1
Recruiting	Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal NCT05526443	Medical University of Graz	—
Completed	HCW9218 for Advanced Pancreatic Cancer NCT05304936	ImmunityBio, Inc.	Phase 1 / Phase 2
Recruiting	Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T NCT05620732	Shenzhen University General Hospital	N/A
Unknown	A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer NCT05257122	Fudan University	Phase 2
Unknown	CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer NCT05143151	Shenzhen University General Hospital	Phase 1 / Phase 2
Completed	Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors o NCT03033225	Mayo Clinic	Phase 2
Completed	Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to NCT01454180	Centro Nacional de Investigaciones Oncologicas CARLOS III	Phase 2